-
1دورية أكاديمية
المؤلفون: Süß, Christoph, Kölbl, Oliver
المصدر: http://lobid.org/resources/99370674185806441Test#!, 197(10):946-949.
مصطلحات موضوعية: Hodgkin Disease/pathology [MeSH], Humans [MeSH], Hodgkin Disease/radiotherapy [MeSH], Antineoplastic Combined Chemotherapy Protocols [MeSH], Literatur Kommentiert, Oncology, Radiotherapy, Radiation Oncology [MeSH]
العلاقة: https://repository.publisso.de/resource/frl:6448597Test; https://doi.org/10.1007/s00066-021-01826-wTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458171Test/
الإتاحة: https://doi.org/10.1007/s00066-021-01826-wTest
https://repository.publisso.de/resource/frl:6448597Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458171Test/ -
2دورية أكاديمية
المؤلفون: Jachimowicz, Ron D., Klapper, Wolfram, Glehr, Gunther, Müller, Horst, Haverkamp, Heinz, Thorns, Christoph, Hansmann, Martin Leo, Möller, Peter, Stein, Harald, Rehberg, Thorsten, von Tresckow, Bastian, Reinhardt, H. C., Borchmann, Peter, Chan, Fong Chun, Spang, Rainer, Scott, David W., Engert, Andreas, Steidl, Christian, Altenbuchinger, Michael, Rosenwald, Andreas
المصدر: http://lobid.org/resources/99370672770606441Test#!, 35(12):3589-3593.
مصطلحات موضوعية: Letter, Cyclophosphamide/therapeutic use [MeSH], Receptor, Platelet-Derived Growth Factor alpha/genetics [MeSH], Etoposide/therapeutic use [MeSH], Neoplasm Staging [MeSH], Male [MeSH], Hodgkin Disease/genetics [MeSH], Ki-1 Antigen/metabolism [MeSH], Prednisone/therapeutic use [MeSH], Hodgkin Disease/pathology [MeSH], Adolescent [MeSH], Female [MeSH], Bleomycin/therapeutic use [MeSH], Hodgkin Disease/drug therapy [MeSH], Adult [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Predictive Value of Tests [MeSH], Middle Aged [MeSH], Procarbazine/therapeutic use [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Survival Rate [MeSH], Ki-1 Antigen/genetics [MeSH], Young Adult [MeSH], Gene Expression Profiling/methods [MeSH], Vincristine/therapeutic use [MeSH], Platelet-Derived Growth Factor alpha/metabolism [MeSH], Transcriptome [MeSH], Chemokine CCL17/genetics [MeSH]
العلاقة: https://repository.publisso.de/resource/frl:6443816Test; https://doi.org/10.1038/s41375-021-01314-1Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632672Test/
الإتاحة: https://doi.org/10.1038/s41375-021-01314-1Test
https://repository.publisso.de/resource/frl:6443816Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632672Test/ -
3دورية أكاديمية
المؤلفون: Damaschin, Carla, Goergen, Helen, Kreissl, Stefanie, Plütschow, Annette, Breywisch, Frank, Mathas, Stephan, Meissner, Julia, Sökler, Martin, Topp, Max S., Vucinic, Vladan, Zimmermann, Andreas, von Tresckow, Bastian, Fuchs, Michael, Engert, Andreas, Borchmann, Peter, Eichenauer, Dennis A.
المصدر: http://lobid.org/resources/99370672770606441Test#!, 36(2):580-582.
مصطلحات موضوعية: Letter, Lymphoma, Clinical Trials, Phase II as Topic/statistics, Neoplasm Recurrence, Local/pathology [MeSH], Neoplasms, Second Primary/pathology [MeSH], Cyclophosphamide/administration, Etoposide/administration, Male [MeSH], Randomized Controlled Trials as Topic/statistics, Bleomycin/administration, Combination drug therapy, Vincristine/administration, Hodgkin Disease/pathology [MeSH], Adolescent [MeSH], Female [MeSH], Follow-Up Studies [MeSH], Hodgkin Disease/drug therapy [MeSH], Second Primary/drug therapy [MeSH], Adult [MeSH], Humans [MeSH], Middle Aged [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Survival Rate [MeSH], Prognosis [MeSH], Young Adult [MeSH], Brentuximab Vedotin/administration, Local/drug therapy [MeSH]
العلاقة: https://repository.publisso.de/resource/frl:6443794Test; https://doi.org/10.1038/s41375-021-01386-zTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807388Test/
الإتاحة: https://doi.org/10.1038/s41375-021-01386-zTest
https://repository.publisso.de/resource/frl:6443794Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807388Test/ -
4دورية أكاديمية
المؤلفون: Frerker, Bernd, Hildebrandt, Guido
المصدر: http://lobid.org/resources/99370674185806441Test#!, 196(5):488-491.
مصطلحات موضوعية: Hodgkin Disease/pathology [MeSH], Adolescent [MeSH], Female [MeSH], Bleomycin/therapeutic use [MeSH], Aged [MeSH], Adult [MeSH], Humans [MeSH], Treatment Outcome [MeSH], Literatur Kommentiert, Middle Aged [MeSH], Oncology, Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Neoplasm Staging [MeSH], Hodgkin Disease/therapy [MeSH], Male [MeSH], Young Adult [MeSH], Positron-Emission Tomography [MeSH], Dacarbazine/therapeutic use [MeSH], Combined Modality Therapy [MeSH], Radiotherapy, Adjuvant [MeSH], Doxorubicin/therapeutic use [MeSH], Vinblastine/therapeutic use [MeSH]
العلاقة: https://repository.publisso.de/resource/frl:6441833Test; https://doi.org/10.1007/s00066-020-01600-4Test
الإتاحة: https://doi.org/10.1007/s00066-020-01600-4Test
https://repository.publisso.de/resource/frl:6441833Test -
5دورية أكاديمية
المؤلفون: Rosenfeldt, Mathias T., Hartmann, Elena M., Leng, Corinna, Rosenwald, Andreas, Anagnostopoulos, Ioannis
المصدر: http://lobid.org/resources/99370678538206441Test#!, 100(10):2635-2637.
مصطلحات موضوعية: Hodgkin Disease/pathology [MeSH], Lymph Nodes/pathology [MeSH], Female [MeSH], Herpesvirus 4, Human/physiology [MeSH], Epstein-Barr Virus Infections/complications [MeSH], Humans [MeSH], Middle Aged [MeSH], Human/isolation, Letter to the Editor, Oncology, Lymph Nodes/virology [MeSH], Hematology, Virus Latency [MeSH], Lymphocytes/virology [MeSH], Hodgkin Disease/virology [MeSH], Epstein-Barr Virus Infections/pathology [MeSH], Lymphocytes/pathology [MeSH], Epstein-Barr Virus Infections/virology [MeSH]
العلاقة: https://repository.publisso.de/resource/frl:6466994Test; https://doi.org/10.1007/s00277-020-04174-4Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440277Test/
الإتاحة: https://doi.org/10.1007/s00277-020-04174-4Test
https://repository.publisso.de/resource/frl:6466994Test
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440277Test/